Posted on 11/20/17
Can This Tiny Biotech Stock Pay Off Big for Celgene?
Celgene Corp (NASDAQ:CELG) loves cozying up to emerging biotech stocks working on next-generation medicine, and one of those collaborations is with Jounce Therapeutics(NASDAQ:JNCE). Celgene inked a . . .
Posted on 11/19/17
Johnson & Johnson: Enticing Valuation
The right time to buy a dividend growth stock is widely debated. No investor wants to feel like they are over paying for a stock, yet . . .
Posted on 11/17/17
Pennsylvania Doctor Opens MDVIP-affiliated Primary Care Practice
MDVIP, the national leader in affordable personalized healthcare, announced today that Matthew Kulka, D.O., has opened an MDVIP-affiliated primary care practice in Langhorne, Pennsylvania, to deliver . . .
Posted on 11/15/17
Celgene (CELG) Presents at 2017 Stifel Healthcare Conference (Transcript)
Celgene Corp. (NASDAQ:CELG)2017 Stifel Healthcare ConferenceNovember 14, 2017 02:45 PM ETExecutivesScott Smith - President and COOTerrie Curran - President, Inflammation and ImmunologyAnalystsTom Shrader - Stifel NicolausTom . . .
Posted on 11/14/17
Your Daily Pharma Scoop: Regeneron's Appeal, Good News For Amgen, Bristol-Myers' Sprycel
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace.Analysis of . . .
Posted on 11/14/17
ADMA Biologics Announces Closing of $42M Follow-On Offering
RAMSEY, N.J. and BOCA RATON, Fla., Nov. 13, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that . . .
Posted on 11/13/17
Zymeworks Inks Deal With Janssen Biotech To Develop Six Bispecific Antibodies
Zymeworks (NYSE:ZYME) inks an agreement with Johnson & Johnson (NYSE:JNJ) unit Janssen Biotech granting it a global license to research, develop and commercialize up to six . . .
Posted on 11/13/17
3 Top Biotech Stocks for 2018
Biotech stocks have been outstanding growth vehicles over the past six-plus years. The industry is still in "hypergrowth" mode because of a number of favorable tailwinds, . . .
Posted on 11/10/17
Onconova Therapeutics Prices Public Offering of Common Stock
NEWTOWN, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug . . .
Posted on 11/9/17
Teva: Stop 'Tucking These Away'
I've only been following the Teva Pharmaceuticals (TEVA) saga since the early August crash caught my attention, but in every article I have read the comments . . .
Posted on 11/9/17
Here's Why Merck & Co., Inc. Tanked 14% in October
What happenedShares of America's second largest pharmaceutical company, Merck & Co., Inc. (NYSE:MRK)suffered their worst month in years, falling 14% in October, according to data from . . .
Posted on 11/9/17
Genesis HealthCare Announces Plans to Strengthen Capital Structure and Reports Third Quarter 2017 Results
KENNETT SQUARE, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced it has . . .
Posted on 11/9/17
Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results
PLYMOUTH MEETING, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported financial results for the quarter ended September 30, 2017.Total revenue was . . .
Posted on 11/8/17
Egalet Announces Third Quarter 2017 Financial Results
Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced . . .
Posted on 11/8/17
Better Buy: Novavax, Inc. vs. Pfizer Inc.
Pfizer (NYSE:PFE) ranks as one of the giants of the pharmaceutical market, with a blockbuster vaccine franchise. Novavax (NASDAQ:NVAX) is only a fraction of Pfizer's size . . .
Posted on 11/8/17
Here's Why Spark Therapeutics, Inc. Fell 9.3% in October
What happenedShares of Spark Therapeutics, Inc. (NASDAQ:ONCE), a clinical-stage biotech advancing a once-and-done gene therapy approach to treating genetic disorders, have given back some of August's . . .
Posted on 11/8/17
Teva: What To Do?
ThesisAfter reviewing Teva's (TEVA) latest results, we are left to conclude that significant downward risks remain. EBITDA continues to worsen and management yet again shows their . . .
Posted on 11/8/17
GSK Consumer Healthcare and CVS Health Partner
In support of Lung Cancer Awareness Month, GSK Consumer Healthcare, CVS Health and the American Lung Association's LUNG FORCE are joining together to help people quit . . .
Posted on 11/8/17
New Jersey Doctor Opens MDVIP-Affiliated Primary Care Practice
MDVIP, the national leader in affordable personalized healthcare, announced that Claudine M. De Dan, M.D., has opened an MDVIP-affiliated practice in Mullica Hill, N.J., to provide . . .
Posted on 11/7/17
Pernix Therapeutics Announces Sale of Non-Core Product
MORRISTOWN, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced the sale of a non-core product, Cedax® . . .
Posted on 11/7/17
Healthcare Administrative Partners’ Clinical Analytics Innovation Receives Industry Recognition
MEDIA, Pa.--(BUSINESS WIRE)--Healthcare Administrative Partners (HAP), a provider of comprehensive revenue cycle management solutions for specialty physician practices, was recently selected to be one of the . . .
Posted on 11/7/17
The Medicines Company and Alnylam Pharmaceuticals Announce Initiation of Phase III Clinical Trials of Inclisiran
PARSIPPANY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced the initiation of the Phase III clinical program . . .
Posted on 11/6/17
Johnson & Johnson Pipeline Impresses
Johnson & Johnson (JNJ) is a $376 billion market cap company trading at $140 per share focused on innovative health care products for people around the . . .
Posted on 11/6/17
The Cost Benefit of Health Care Transparency
As our nation seeks solutions to help improve the healthcare system, there is at least one goal we can all agree on: the importance of making . . .
Posted on 11/6/17
5 Tips To Help Americans Prepare For Open Enrollment And Save On Healthcare Costs
More than 70 percent of Americans say they are prepared for open enrollment, yet most people struggle to understand basic health insurance terms, according to a . . .

